Literature DB >> 33646281

Clinical Trials Without Clinical Sites.

Steven R Cummings1,2.   

Abstract

Clinical trials conducted at clinical sites are limited to enrolling people who live nearby and are able to attend visits at clinics. Some types of clinical trials can be performed without clinical sites, which enables people to participate regardless of proximity to a clinical site or limitations that make visits difficult. Trials at clinical sites involve face-to-face relationships with in-person collection of informed consent, examinations, data, and specimens. In contrast, without clinical sites, informed consent and data are obtained online, limited examinations can be performed by telemedicine or visiting research nurses, biospecimens can be collected by visiting nurses or local laboratories, and treatments can be sent to homes or administered by nurses in participants' homes. Trials without clinical sites require internet access and must adapt to the lack of face-to-face interactions with study staff, with communication conducted by email, telephone, or video. Many trials cannot be performed entirely without clinical sites because they require examinations, tests, or treatments that must be given at a clinical site. However, some of the methods required for trials without sites, such as online data collection, follow-up visits by telemedicine or research nurses, and delivery of treatments to home, could reduce the need for visits to clinical sites and reduce the burden of participating in a clinical trial. When feasible, conducting clinical trials without clinical sites has the potential to expand participation and the generalizability of their results.

Entities:  

Mesh:

Year:  2021        PMID: 33646281     DOI: 10.1001/jamainternmed.2020.9223

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  8 in total

Review 1.  Mental Health Clinical Research Innovations during the COVID-19 Pandemic: The Future Is Now.

Authors:  Kelly B Ahern; Eric J Lenze
Journal:  Psychiatr Clin North Am       Date:  2021-11-12

2.  Digital health device measured sleep duration and ideal cardiovascular health: an observational study.

Authors:  Jane A Leopold; Elliott M Antman
Journal:  BMC Cardiovasc Disord       Date:  2021-10-14       Impact factor: 2.298

3.  Does m-health-based exercise (guidance plus education) improve efficacy in patients with chronic low-back pain? A preliminary report on the intervention's significance.

Authors:  Fuming Zheng; Shufeng Liu; Shanshan Zhang; Qiuhua Yu; Wai Leung Ambrose Lo; Tingni Li; Chu Huai Wang
Journal:  Trials       Date:  2022-03-03       Impact factor: 2.728

4.  Deployment of an End-to-End Remote, Digitalized Clinical Study Protocol in COVID-19: Process Evaluation.

Authors:  Nicole Zahradka; Juliana Pugmire; Jessie Lever Taylor; Adam Wolfberg; Matt Wilkes
Journal:  JMIR Form Res       Date:  2022-07-29

5.  From hybrid to fully remote clinical trial amidst the COVID-19 pandemic: Strategies to promote recruitment, retention, and engagement in a randomized mHealth trial.

Authors:  Leigh Ann Simmons; Jennifer E Phipps; Mackenzie Whipps; Paige Smith; Kathryn A Carbajal; Courtney Overstreet; Jennifer McLaughlin; Koen De Lombaert; Devon Noonan
Journal:  Digit Health       Date:  2022-09-25

6.  Building and implementing a contactless clinical trial protocol for patients with COVID-19: A Korean perspective.

Authors:  Ye Seul Bae; Sumi Sung; Jungeun Lee; Hyeonji Lee; Eui Kyu Chie
Journal:  Front Med (Lausanne)       Date:  2022-09-15

7.  Impact of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials.

Authors:  Katia Audisio; Hillary Lia; Newell Bryce Robinson; Mohamed Rahouma; Giovanni Soletti; Gianmarco Cancelli; Roberto Perezgrovas Olaria; David Chadow; Derrick Y Tam; Dominique Vervoort; Michael E Farkouh; Deepak L Bhatt; Stephen E Fremes; Mario Gaudino
Journal:  J Cardiovasc Dev Dis       Date:  2022-01-10

Review 8.  [Benefit assessment of digital health applications-challenges and opportunities].

Authors:  Lars G Hemkens
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-09-15       Impact factor: 1.513

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.